lunes, 28 de agosto de 2023
CDER Small Business and Industry Assistance (SBIA) Presents Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials
CDER Small Business and Industry Assistance (SBIA)
Presents
https://www.fda.gov/drugs/news-events-human-drugs/use-biomarkers-diagnosing-and-assessing-treatment-response-noncirrhotic-nash-trials-09182023?utm_medium=email&utm_source=govdelivery
Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials
https://www.fda.gov/media/171426/download?attachment=&utm_medium=email&utm_source=govdelivery
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario